Anti-VEGFR2 therapy delays growth of preclinical pediatric tumor models and enhances anti-tumor activity of chemotherapy

por Lowery, Caitlin D., Blosser, Wayne, Dowless, Michele, Renschler, Matthew, Perez, Lisa V., Stephens, Jennifer, Pytowski, Bronislaw, Wasserstrom, Heather, Stancato, Louis F., Falcon, Beverly
Publicado 2019

An In Vitro Cord Formation Assay Identifies Unique Vascular Phenotypes Associated with Angiogenic Growth Factors

por Falcon, Beverly L., Swearingen, Michelle, Gough, Wendy H., Lee, Linda, Foreman, Robert, Uhlik, Mark, Hanson, Jeff C., Lee, Jonathan A., McClure, Don B., Chintharlapalli, Sudhakar
Publicado 2014

Development and characterization of a high-throughput in vitro cord formation model insensitive to VEGF inhibition

por Falcon, Beverly L, O’Clair, Belinda, McClure, Don, Evans, Glenn F, Stewart, Julie, Swearingen, Michelle L, Chen, Yuefeng, Allard, Kevin, Lee, Linda N, Neote, Kuldeep, McEwen, Dyke P, Uhlik, Mark T, Chintharlapalli, Sudhakar
Publicado 2013

Merestinib (LY2801653) inhibits neurotrophic receptor kinase (NTRK) and suppresses growth of NTRK fusion bearing tumors

por Konicek, Bruce W., Capen, Andrew R., Credille, Kelly M., Ebert, Philip J., Falcon, Beverly L., Heady, Gary L., Patel, Bharvin K.R., Peek, Victoria L., Stephens, Jennifer R., Stewart, Julie A., Stout, Stephanie L., Timm, David E., Um, Suzane L., Willard, Melinda D., Wulur, Isabella H., Zeng, Yi, Wang, Yong, Walgren, Richard A., Betty Yan, Sau-Chi
Publicado 2018